Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

Clinical trial NCT05284591 · COMPLETED

Trial details

NCT number: NCT05284591
Sponsor: iOMEDICO AG
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma Newly Diagnosed Transplant Ineligible Patient Satisfaction Patient Preference Personal Satisfaction

Start date: 2022-07-06
Primary completion: 2024-09-20
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.